Annals of Antivirals and Antiretrovirals Submit Manuscript

    Analysis of baseline laboratory characteristics of HIV-positive patients in Bulgaria treated with bictegravir /emtricitabine/ tenofovir anafelamide (early analysis)

    DOI Logo 10.17352/aaa.000018

    Published On: January 04, 2024 | Pages: 001 - 007

    Author(s): Dimitar Strashimirov*, Ralitsa Yordanova, Rusina Grozdeva, Evgeni Penchev, Daniel Ivanov and Nina Yancheva-Petrova

    ORCID Logo  0000-0001-9053-6949

    Introduction: Bictegravir/Emtricitabine/Tenofovir Anafelamide (B/F/TAF) is a recommended single tablet regimen with good tolerability and safety as well as durability of the virologic response. From its introduction in the country of Bulgaria in April 2021 till November 2021 it was given to 82 patients, followed up and treated in the Department for HIV at the Prof. Iv ... CrossMark Publons Harvard Library HOLLIS Search IT Semantic Scholar Get Citation Base Search Scilit OAI-PMH ResearchGate Academic Microsoft GrowKudos Universite de Paris UW Libraries SJSU King Library SJSU King Library NUS Library McGill DET KGL BIBLiOTEK JCU Discovery Universidad De Lima WorldCat VU on WorldCat
    Abstract View Full Article View